Rchr
J-GLOBAL ID：200901099937889393
Update date: Jan. 30, 2024
Inoue Hiromasa
イノウエ ヒロマサ | Inoue Hiromasa
Affiliation and department：
Job title：
Professor
Homepage URL (1)：
http://www.kufm.kagoshima-u.ac.jp/~pulmo/index.html
Research field (2)：
Allergies and connective tissue disease
, Respiratory medicine
Research keywords (8)：
脂質メディエーター
, サイトカイン
, 慢性閉塞性肺疾患
, 気管支喘息
, cytokine
, treatment
, pathophysiology
, asthma
Research theme for competitive and other funds (32)：
- 2021 - 2024 TL1A/DR3シグナルを介したステロイド抵抗性のメカニズム
- 2021 - 2024 自然リンパ球と脂質分子に注目した難治性喘息の病態解析
- 2020 - 2023 気管支喘息の病態における気道上皮糖鎖修飾の役割についての解析
- 2018 - 2021 The role of phospholipase A2/lysophospholipids in the pathogenesis of refractory respiratory diseases
- 2018 - 2021 血液・気道上皮被覆液を用いた呼吸器疾患バイオマーカーの解析
- 2017 - 2020 New phospholipase A2 and pathophysiology of asthma
- 2016 - 2019 The role of TRP channel in the pathogenesis of antigen-nonspecific asthma exacerbation
- 2016 - 2018 Investigation of the common RNA networks in lung cancer and idiopathic pulmonary fibrosis for the new strategy of the diseases.
- 2015 - 2018 The role of new lipid mediator in the pathogenesis of interstitial pneumonia
- 2015 - 2018 Study of biomarkers in respiratory disease based on the expression analysis of miRNAs in blood and epithelial lining fluid.
- 2013 - 2017 The investigation of non-neuronal cholinergic inflammtation in bronchial asthma
- 2013 - 2016 The role of Angptl2 expression in lung for interstitial pneumonia
- 2012 - 2016 Role of angiopoietin-like protein in the pathogenesis of interstitial pneumoniae
- 2012 - 2015 Elucidation of the involvement of the inflammatory response and development of a new marker and treatment in lung cancer growth
- 2011 - 2014 Analysis of molecular mechanism of anti-asthmatic activity of allosamidin by focusing the function of chitinase-like proteins
- 2011 - 2012 Development of novel antibody therapy for refractory asthma
- 2009 - 2011 Preclinical study for therapy with siRNA targeting cell-to-cell communications in obstructive lung diseases
- 2008 - 2010 Development of chemical biology based on allosamidin molecule
- 2007 - 2008 Development of second generation therapeutic strategy based on genome information
- 2006 - 2007 Investigating the pathogenic role and its novel intervention of virus-associated double-stranded RNA in asthma
- 2005 - 2007 Analysis of a physiological role and anti-asthmatic activity of the chitinase inhibior allosamidin
- 2005 - 2006 Modulation of Cytokine Signals and Treatment for Inflammatory Lung Diseases
- 2004 - 2005 Investigation of regulatory role and therapeutic potential of B7-DC in bronchial asthma
- 2003 - 2004 Role of regulator of cytokine signaling in asthma and COPD
- 2000 - 2001 Control of airway remodeling in animal models of asthma and chronic inflammatory airway diseases
- 1999 - 2000 Mutual Interaction between Airway Inflammation and β-Adrenoceptor Function
- 1998 - 1999 Eosinophilic Airway Inflammation and Airway Remodeling
- 1997 - 1998 Studies fro the role of nitric oxide in bronchial asthma
- 1995 - 1995 気道におけるInterleukin-8発現の制御に関する研究
- 1995 - 1995 タバコ煙により引き起こされる気道炎症・気道過敏性についての研究
- New Treatment of COPD
- Mechanism of Airway Hyperresponsiveness and Airway Inflammation
Show all
Papers (227)：
-
Yoko Hagihara, Yuya Tomioka, Takayuki Suetsugu, Masahiro Shinmura, Shunsuke Misono, Yusuke Goto, Naoko Kikkawa, Mayuko Kato, Hiromasa Inoue, Keiko Mizuno, et al. Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma. Cancers. 2023. 15. 23
-
Kengo Tanigawa, Yuya Tomioka, Shunsuke Misono, Shunichi Asai, Naoko Kikkawa, Yoko Hagihara, Takayuki Suetsugu, Hiromasa Inoue, Keiko Mizuno, Naohiko Seki. Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets. FEBS open bio. 2023
-
Yuya Tomioka, Takayuki Suetsugu, Naohiko Seki, Kengo Tanigawa, Yoko Hagihara, Masahiro Shinmura, Shunichi Asai, Naoko Kikkawa, Hiromasa Inoue, Keiko Mizuno. The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma. Cells. 2023. 12. 14
-
Kenji Kawatoko, Yasuyoshi Washio, Tomoyuki Ohara, Satoru Fukuyama, Takanori Honda, Jun Hata, Taro Nakazawa, Keiko Kan-o, Hiromasa Inoue, Koichiro Matsumoto, et al. Risks of dementia in a general Japanese older population with preserved ratio impaired spirometry: The Hisayama Study. Journal of Epidemiology. 2023
-
Kengo Tanigawa, Shunsuke Misono, Keiko Mizuno, Shunichi Asai, Takayuki Suetsugu, Akifumi Uchida, Minami Kawano, Hiromasa Inoue, Naohiko Seki. MicroRNA signature of small cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control. Molecular oncology. 2022
ｍore...
MISC (132)：
-
鶴薗 健太郎, 冨岡 勇也, 大脇 一人, 谷川 健悟, 美園 俊祐, 近藤 清貴, 内田 章文, 末次 隆行, 水野 圭子, 井上 博雅. 当院の進行肺腺癌症例におけるTTF-1発現とペメトレキセド(PEM)の治療反応性の検討. 日本呼吸器学会誌. 2022. 11. 増刊. 174-174
-
末次 隆行, 谷川 健悟, 上川路 和人, 隈元 朋洋, 田村 誠也, 水野 圭子, 岩川 純, 井上 博雅. EGFR遺伝子変異陽性肺癌患者におけるafatinib投与の観察研究. 肺癌. 2020. 60. 6. 764-764
-
下馬場 健一, 高木 弘一, 坂上 公太, 新村 昌弘, 三山 英夫, 籾 博晃, 水野 圭子, 井上 博雅. 肺線維症の病因・病態 びまん性肺疾患の病態におけるTET遺伝子の関わり. 日本呼吸器学会誌. 2020. 9. 増刊. 124-124
-
宮田 真里奈, 末次 隆行, 福田 宏正, 砂永 祐介, 三山 英夫, 籾 博晃, 水野 圭子, 井上 博雅. 当科における非小細胞肺癌に対する免疫チェックポイント阻害剤の効果と安全性の検討. 日本呼吸器学会誌. 2020. 9. 増刊. 170-170
-
堂嶽 洋一, 新村 昌弘, 籾 博晃, 水野 圭子, 井上 博雅. クリゾチニブの投与を行ったROS1遺伝子転座陽性肺腺癌の2症例. 肺癌. 2019. 59. 3. 305-306
ｍore...
Patents (1)：
Professional career (1)：
Awards (3)：
- 2005 - 日本アレルギー学会 学術大会賞
- 2005 - 日本呼吸器学会 熊谷賞
- 1996 - 日本胸部疾患学会・学会奨励賞
Association Membership(s) (7)：
日本肺癌学会
, American Association of Immunologists
, 日本免疫学会
, 日本アレルギー学会
, AMERICAN THORACIC SOCIETY
, 日本内科学会
, 日本呼吸器学会
